Position history for BlackRock, Inc.'s holdings in ARCUTIS BIOTHERAPEUTICS INC
BlackRock, Inc. holds 9.1M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $264.3M as of 2025-Q4. The position was increased (++6.1% shares). ARQT represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$264.3M
Current Shares
9.1M
Total Value Change
+$136.8M
Total Shares Change
-48,979
Other major holders of ARQT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 9.1M |
+6.1% |
| $264.3M |
| 0.0% |
| $28.08 |
33 |
| 2025-Q3 | Increased | 8.6M | +0.5% | $161.6M | 0.0% | $18.62 | 30 |
| 2025-Q2 | Decreased | 8.5M | -4.0% | $119.6M | 0.0% | $13.74 | 0 |
| 2025-Q1 | Decreased | 8.9M | -2.8% | $139.1M | 0.0% | $15.73 | 0 |
| 2024-Q4 | New | 9.1M | - | $127.4M | 0.0% | $14.20 | 42 |